Clinical Trial Update: Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing tolerability of a foaming facial cleanser and SPF 30 moisturizer in children aged 7-11 with acne-prone skin; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Prone Skin

Drugs mentioned

• Foaming Facial Cleanser
• Moisturizer SPF 30

Snippet

Sponsor: Galderma R&D | Conditions: Acne Prone Skin | Phase 4 | Status: COMPLETED | Results posted: 2014-03-24